48 results about "Parotid gland" patented technology

The externally applied Chinese herbal medicine for treating mammary cancer and lumph cancer is prepared with 11 kinds of Chinese medicinal materials, including frankincense, myrrh, dragon's blood, catecu, angelica, etc. The externally applied Chinese herbal medicine may be used to treat mammary cancer, lumph cancer, carcinoma of parotid gland and other malignant tumors in epithelial tissue, and has fast acting, high curative rate, no pain and no toxic side effect.

The invention discloses a traditional Chinese medicine composition formula for treating calculosis, composed of desmodium, digua fig stem and leaf, lygodium japonicum, China fir, tuckahoe, corn silk, weeping willow and fringed pink. The pharmaceutical composition has the effects on clearing away heat, promoting diuresis, promoting blood circulation, relieving pain, removing calculus and inducing diuresis, can be used for treating different sizes of calculuses in hepatic ducts, parotid gland, lacrimal gland, bile ducts and gall bladder and urethral calculus in kidney, nephric ducts, bladder and the like, also can be used for treating calculus pain, retention of urine and other related complications, and is a relatively ideal clinical therapeutic medicament for calculosis. In addition, the medicament is not found having any toxic side effects and has certain preventive effects on all kinds of calculosis if a small dose of medicament is taken for a long time.

The invention aims at providing a medicine for treating trauma infectious diseases of animals. The medicine is prepared by compatibility of traditional Chinese medicines and is characterized by being prepared from the following medicinal raw materials: sensitive smithia herb, common wedgelet fern herb, leaf of tree-of-heaven ailanthus, naked flower beautyberry branchlet and leaf, symplocos sumuntia, tongking pepper, shinyleaf pricklyash root, winged euonymus twig, dracontomelon duperreanum, toosendan leaf, limonium bicolor, camphor root, native copper, semen strychni, striate loosestrife, radix stemonae, solamum melongena, rhizoma coptidis, schefflera arboricola hayata, fragile blueberry leaf, yichang viburnum branchlet and leaf, sulphur, radix sileris and cortex moutan. The medicine has main effects of inhibiting bacteria and resisting infection, activating blood to remove stasis, relieving swelling and pain, detoxicating, astringing furuncle, removing the necrotic tissue, promoting granulation and promoting wound healing and very remarkable curative effects on trauma infection of the animals caused by various reasons, such as incised wound, bite wound, cellulitis, anal gland abscess of dogs, alveoli fistula, cattle footrot, parotid abscesses, skin ulcers, muscle rot and old healed trauma.

The invention aims to provide a medicine for treating animal traumatic infection diseases, which is formed by drug matching. The medicine is characterized by being prepared from following raw material medicines of leeches, mustards, all grass of highstalk razorsedge, fragile blueberry leaves, root of woody hawkbeard, tongking pepper, zanthoxylum nitidum DC, winged euonymus twig, corydalis bungeana, concha haliotidis, lygodium japonicum, golden-rod, polygonum aviculare, phoenix-tail fern, Indian nightshade root, lithargite, root of heartleaf viburnum, Chinese actinidia root, cayenne pepper and lysimachia christinae hance. The medicine mainly has the effects of inhibiting bacteria and resisting infection, removing blood and removing stasis, relieving swelling and pain, detoxifying and healing sores, removing the necrotic tissue and promoting granulation and promoting wounds to be healed. With the regard to external wound infection caused by various reasons of animals, such as knife wounds, bite wounds, cellulitis, dog anal gland abscess, gullet fistula, cow foot rot, parotid gland abscess, body surface ulcer, muscle rot, and old and difficultly-healed wounds, the medicine has the very obvious curative effect.

The invention discloses a post operation head maxilla part elastic sleeve for a maxillofacial part. The post operation head maxilla part elastic sleeve is characterized by comprising a head cover which is made of elastic cloth, the lower end of the head cover can directly reach the neck of a human body, the part, corresponding to the face of the human body, of the front face of the head cover is provided with a front opening, the parts, corresponding to the ears of the human body, of the two sides of the head cover are provided with side openings, the parts, corresponding to the two sides of the lower mandible of the human body, of the outer side of the head cover are each connected with a pair of elastic belts, nylon hasps are arranged on the faces of the free ends of the elastic bands, and the parts, on the two sides of the side openings, of the head cover are provided with nylon hasps. Compared with the prior art, the post operation head maxilla part elastic sleeve has the advantages that post operation appropriate pressurizing binding on maxillofacial fractures and parotid glands can achieved for preventing post operation complications, meanwhile, the living quality of a patient is not influenced obviously, and the phenomena of local lymphatic return obstruction, hematoma, hydrops and even allergies, blistering and the like are avoided.

An implant device for placement within a salivary gland duct having a first end adjacent a parotid gland and a second end adjacent a submandibular gland. The implant device comprises an elongate body having a lumen, and a first and a second plate offset from the proximal end of the elongate body. The first plate is located on one side of the elongate body and the second plate is located on the other side of the elongate body. The first plate includes a first and a second hole operable to suture the first plate to a location adjacent the parotid gland. The second plate includes a first and a second hole operable to suture the second plate to a location adjacent the submandibular gland.

The invention relates to a traditional Chinese medicine for preventing and treating adverse reactions after radiation on head and neck tumors. The traditional Chinese medicine is prepared from the following traditional Chinese medicine materials in parts by weight: 5-15 parts of radix ophiopogonis, 5-15 parts of asparagus cochinchinensis, 5-15 parts of adenophora stricta,5-15 parts of schisandra chinensis, 5-15 parts of codonopsis pilosula, 5-15 parts of honeysuckle, 5-15 parts of rhizoma polygonati, 5-15 parts of matrimony vine, 3-9 parts of chrysanthemum and 10-20 parts of Chinese yam. The traditional Chinese medicine is non-toxic, harmless, and scientific in formula; all the medicine materials contained in the traditional Chinese medicine are compatible and jointly play the effects of protecting a parotid gland and a salivary gland, regulating immune and relieving oral mucosa reactions; and the traditional Chinese medicine is convenient to take and remarkable in treatment effect.

The invention discloses an externally applied herbal cream for treating infantile mumps. The traditional Chinese medicine thinks that the infantile mumps is caused by wind-warm epidemic toxins, pathogenic factors enter the lung and the stomach through the nose and the mouth, heat is transferred to the liver and the gall and then accumulated and undispersed, and then the heat is gathered into sputum which causes that parotid glands are hot, swelling and pain. Therefore, the herbal cream disclosed by the invention is prepared through selecting traditional Chinese medicines such as java speedwell, sinkiang arnebia roots, rhizoma pleionis, rhizoma typhonii, radix sophorae flavescentis and rhizoma coptidis as raw materials and adding a right amount of honey into the raw materials. The herbal cream is externally applied to an affected part; and through clinical trials, the herbal cream has a good curative effect, the total effective rate reaches 98.4%, and the herbal cream has no toxic or side effect; and the herbal cream is simple in treatment method, and especially suitable for children use.

The invention discloses a postoperative dressing pressurizing device for parotid gland. The parotid gland postoperative dressing pressurizing device comprises a head fixing band and a pressurizing band, the head fixing band is connected with the two ends of the pressurizing band respectively, a pressurizing assembly is arranged at the position, corresponding to the parotid gland of the human body, of the inner side of the pressurizing band, and the pressurizing assembly comprises a plurality of pressurizing air bags; a plurality of pressurization cavities are formed in the pressurization air bag, one end of each pressurization cavity is connected with an air inlet branch pipe, the ends, away from the pressurization cavities, of all the air inlet branch pipes are converged and connected with an air inlet main pipe, and one end of the air inlet main pipe penetrates through the pressurization belt and extends to the outer side of the pressurization belt; by means of the technical scheme, the postoperative dressing pressurizing device has the advantage of being good in wound binding, and good postoperative recovery is guaranteed.

The invention relates to a specimen making method for a human cerebrovascular interventional operation, which comprises the following steps of selecting a human specimen and performing preservative treatment on the human specimen; selecting materials, wherein the head, the thorax and the abdomen are reserved, part of ribs and sternum are removed, upper limbs on the two sides are removed, and the middles of thighs are cut open; annularly sawing the top of the craniotomy, removing skin superficial fascia on the right side of the face, displaying parotid gland, removing skin superficial fascia onthe left side of the face, and exposing maxillary artery and branches; reserving partial skin and superficial fascia on the right side of the lower limb, removing the skin and superficial fascia on the left side, and displaying great saphenous veins, femoral arteries and branches; in the thoracic cavity: removing superficial fascia and deep fascia, and exposing heart appearance and head and arm stems; bleaching and washing the specimen; cleaning redundant tissues on the surface of the specimen; threading a guide wire, wherein in the right groin area, the guide wire is slowly inserted along the femoral artery till the common iliac artery, the internal carotid artery and the basilar artery are reached. And the prepared specimen has strong sense of reality, is beneficial to specimen observation, and is convenient for teaching and learning.

The invention discloses paste for treating epidemic mumps and a method for preparing the paste. The paste comprises cactus squeezed liquid, aloe squeezed liquid, honeysuckle extract liquid, peppermint extract liquid, cortex dictamni extract liquid, wild chrysanthemum extract liquid, scutellaria baicalensis extract liquid, aloe oil, borage oil, calendula oil, glycerin, ethylparaben, water-soluble Ve (vitamin E), omnipotence emulsifiers G57, ice crystal forming agents AVC and distilled water. Compared with the prior art, the paste and the method have the advantages that the paste is mild in medicine property and high in safety, excellent epidemic mumps treatment effects can be realized by active substances in natural medicines, and obvious effects of diminishing inflammation and swelling, clearing heat, removing toxicity, promoting blood circulation to remove blood stasis and dredging parotid gland meridians can be realized by the paste; the paste is locally applied and is safe in use, free of side effects, high in osmosis and durable in efficacy, obvious treatment effects for improving the mumps can be realized if the paste is used for a long time, symptoms and root causes can be treated, and accordingly patients can be kept away from the mumps; excellent prevention effects can be realized by the paste.

The invention discloses a method for preparing a human nerve growth factor using a transgenic pig salivary gland. A transgenic pig which can specifically express human NGF in a parotid gland is prepared through a transgenic method, secreted saliva of the transgenic pig is collected to separate and purify the human NGF to be used for the treatment of human diseases, and the human NGF has a significant effect particularly on the treatment of human neurological diseases. Currently developed and clinically used NGF medicines on the market are murine NGF, murine saliva amount is less, endogenous secreting amount is less, the separation purifying amount is less, so that the marketing price is high; although the homology of murine NGF and human NGF is high, there still exists the problem of immunogenicity in the murine NGF, which might cause untoward reactions of allergy and the like. The method has the advantages that efficient and high-yield human NGF proteins in the transgenic pig are obtained, the problem of low murine NGF yield is solved, and the homology problem is solved.

The invention discloses a traditional Chinese medicine composition for treating yin-deficiency heat toxin type radiation-induced salivary gland damage. According to the traditional Chinese medicine, radiotherapy rays are heat toxins, and symptoms such as heat toxin-induced body fluid impairment and yin and body fluid deficiency can be caused after radiotherapy. Therefore, traditional Chinese medicines such as Chinese Ladiestresses Root or Herb, bornet cowlily rhizome, membrane of hen egg, dunn antiotrema root, Antidesma bunius, Goldhair Hedyotis Herb, trollflower, endive, Canscora lucidissima, crataeva leaf, Hypericum ascyron and cephalanoplos setosum with the effects of nourishing yin and clearing heat and detoxifying and activating blood circulation are selected to be decocted into decoction by adding water. The clinical test proves that saliva flow velocity, amylase secretion rate and increase of secretion rate of the parotid gland and salivary gland in a treatment group are superior to those in a control group, and the living quality of patients is obviously improved.

Disclosed is the in vitro use of at least one lectin which recognises the fucose alpha(1-2) galactose unit for labelling cancer stem cells of organs involved in respiration, in order to obtain labelled cancer stem cells of organs involved in respiration, in a biological sample. In one particular embodiment, the at least one lectin is chosen from the lectins Ulex Europaeus agglutinin 1 (UEA-1) or the homologue thereof, Trichosanthes japonica agglutinin II (TJA-II), Agaricus Bisporus agglutinin (ABA), Amaranthus Caudatus agglutinin (ACA), jacalin, Griffonia Simplicifolia lectin I (GSL-I) and Griffonia Simplicifolia lectin II (GSL-II). In one particular embodiment, the organ involved in respiration is chosen from the lungs, the larynx, the pharynx, the mouth, the nose, the throat, the tongue, the sinuses, the trachea and the saliva glands including the tonsils and the parotid gland.

The present invention includes a method of treating pain caused by neuralgia comprising administering botulinum toxin to an afflicted area of a patient. The pain may be caused by trigeminal neuralgia or be associated with dental extraction or reconstruction, and may be facial pain. The neuralgia may be associated with compressive forces on a sensory nerve, intrinsic nerve damage, demyelinating disease, a genetic disorder, a metabolic disorder, central neurologic vascular disease, or trauma. The present invention also includes a method of treating post-operative incisional wound pain comprising administering botulinum toxin to an afflicted area of a patient. The post-operative incisional wound pain may be associated with medical treatments selected from the group consisting of sinus surgery, removal of an eye, temporal mandibular joint surgery, parotid gland extraction and resection, craniotomy for removal of an intracranial tumor, intra-ocular surgery, acoustic neuroma surgery, reconstructive procedures after tumor resection, radiation therapy for the treatment of cancer, skull base surgery, orbitectomy, facial bone removal, muscle removal, skin removal, and construction of myocutaneous flaps.